Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Edesa Biotech, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +1 vs. Q1 2025
- Shares held
- 2.11M
- −714.3K (−25.3%) vs. Q1 2025
- Total value
- $4.28M
- −$2.61M (−37.9%) vs. Q1 2025
- New holders
- 4
- 4 more added
- Sold out
- 3
- 2 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $30.0M |
| Q1 2026 | 28 | $13.8M |
| Q4 2025 | 22 | $4.34M |
| Q3 2025 | 23 | $7.10M |
| Q2 2025 | 20 | $4.28M |
| Q1 2025 | 20 | $6.89M |
| Q4 2024 | 17 | $350.1K |
| Q3 2024 | 18 | $718.2K |
| Q2 2024 | 17 | $645.1K |
| Q1 2024 | 17 | $450.9K |
| Q4 2023 | 19 | $507.1K |
| Q3 2023 | 20 | $1.26M |
| Q2 2023 | 22 | $1.63M |
| Q1 2023 | 26 | $2.05M |
| Q4 2022 | 22 | $3.53M |
| Q3 2022 | 21 | $494.2K |
| Q2 2022 | 24 | $2.26M |
| Q1 2022 | 23 | $5.51M |
| Q4 2021 | 26 | $2.03M |
| Q3 2021 | 23 | $2.85M |
| Q2 2021 | 18 | $1.37M |
| Q1 2021 | 16 | $773.7K |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Dogwood Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 1 | $2 | 0.00% | +1 | New |
| Global Retirement Partners, LLC | 25 | $51 | 0.00% | +25 | New |
| Raymond James Financial Inc | 29 | $59 | 0.00% | +29 | New |
| Bank of America Corp | 54 | $109 | 0.00% | +32+145.5% | Added |
| Fifth Third Bancorp | 100 | $203 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 142 | $288 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 584 | $1.19K | 0.00% | +584 | New |
| UBS Group AG | 683 | $1.39K | 0.00% | +679+16,975.0% | Added |
| Royal Bank of Canada | 1,816 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,343 | $4.76K | 0.00% | +1,151+96.6% | Added |
| Vanguard Group Inc | 15,864 | $32.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 23,514 | $47.5K | 0.00% | +6,923+41.7% | Added |
| Geode Capital Management, LLC | 27,956 | $56.5K | 0.00% | −1,014−3.5% | Reduced |
| Commonwealth Equity Services, LLC | 35,003 | $71.0K | 0.00% | −15,000−30.0% | Reduced |
| Nantahala Capital Management, LLC | 625,000 | $1.27M | 0.09% | 00.0% | Unchanged |
| Rubric Capital Management LP | 687,500 | $1.40M | 0.02% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 687,500 | $1.40M | 1.40% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −687,500−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −19,999−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Credit Agricole S A | – | – | – | – | Not filed |